七月 2026
- Home
- Beta Bionics
七月 2026的Beta Bionics市场份额分析
Discover real-world data on the iLet Bionic Pancreas. Explore insights and outcomes that showcase its impact on diabetes management in clinical settings.
Beta Bionics(包含公司地区分支机构)
查看更多网站流量和参与度信息- betabionics.com
Beta Bionics收入截至 七月 2026为 50M - 75M
Beta Bionics主要域名产生的收入
3 年中Beta Bionics主要域名的收入
Beta Bionics主要域名的收入
Beta Bionics热门域名的总访问量
了解Beta Bionics市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Beta Bionics热门域名的平均访问时长
分析Beta Bionics参与度指标。
过去 3 个月的平均访问时长
子公司明细
Beta Bionics热门域名的平均页面浏览量
了解Beta Bionics如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Beta Bionics 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Abbott will integrate with Beta Bionics, Inc. on Dec 31st '26.Abbott plans to connect the Libre Duo with Beta Bionics' iLet and Sequel Med Tech's twiist insulin pumps by late 2026, as first reported by HIT Consultant.
八月 26, 2026阅读更多
新闻Abbott will integrate with Beta Bionics, Inc. on Dec 31st '26.Abbott expects compatibility with Beta Bionics' iLet and Sequel Med Tech's twiist automated insulin delivery (AID) systems by the end of 2026, followed by devices from Insulet and Tandem in 2027.
八月 26, 2026阅读更多
新闻Beta Bionics, Inc. had revenue of $32M on Jul 1st '26.Beta Bionics NASDAQ: BBNX reported second-quarter 2026 net sales of $32 million, up approximately 38% from a year earlier, as new patient starts and recurring pharmacy-channel supply revenue supported growth for its iLet insulin-delivery system.
七月 29, 2026阅读更多
查看 Beta Bionics 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
